Business Council

The New York Stem Cell Foundation's Business Council is comprised of leaders from biotechnology, pharmaceutical and venture capital companies who share the Foundation's vision and mission to advance stem cell research.

NYSCF understands the critical importance of creating partnerships with industry to further this innovative research. The Business Council assists the Foundation in developing strategies for working with the private sector to advance stem cell research, establishing collaborations with industry partners to maximize the possibilities of developing therapeutics derived from research supported by NYSCF.

Scott Bruder, MD, PhD

Chief Medical and Science Officer - Stryker Corporation

Eli Casdin

Casdin Capital

Ashley Dombkowski, PhD

Chief Business Officer and VP of Operations - 23andMe

Geoff Duyk, MD, PhD

Partner - TPG Biotech LLC

Corey Goodman, PhD

President, Biotherapeutics and Bioinnovation Center - Pfizer

Daniel Marshak, PhD

Senior Vice President & Chief Scientific Officer - PerkinElmer

Mahendra Rao, PhD

Director-NIH Center for Regenerative Medicine at National Institutes of Health and former Vice President of Research, Life Technologies

George Scangos, PhD

Chief Executive Officer - Biogen Idec

Richard Scheller, PhD

Executive Vice President, Research and Chief Scientific Officer - Genentech

Joop Sistermans

Former Executive Vice President - Akzo Nobel

Patrick Vallance, MD, PhD

Senior Vice President of Drug Discovery - GlaxoSmithKline

NYSCF Cell Images

You are here: About Us Business Council